• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

uterine fibroids

Myovant Sciences uterine fibroids drug Myfembree relugolix
Marketing

Myovant endometriosis survey shows crippling effect on women

A new survey out by Myovant and Evidation is shining a spotlight on the crippling reality for women living with endometriosis or uterine fibroids.
Jacqueline Renfrow May 19, 2023 7:25am
Myovant Sciences uterine fibroids drug Myfembree relugolix

Myovant rejects Sumitomo's buyout offer—at least for now

Oct 3, 2022 11:04am
layoff staff workforce

ObsEva will slash 70% of its staff, saving $7.6M annually

Sep 13, 2022 10:29am
Stethascope and uterus

Myovant touts Pfizer-partnered drug launch plans

Jul 29, 2022 7:20am
Myovant Sciences uterine fibroids drug Myfembree relugolix

FDA knocks Myovant, Pfizer's NDA for Myfembree off track

Apr 12, 2022 9:31am
Hologic campaign urges Black women to get loud about equal care for uterine fibroids

Hologic urges Black women to 'get loud' about uterine fibroids

Dec 10, 2021 3:25pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings